Skip to main content
Not Found
Digital Seminar

Antibiotic Selection for the Geriatric Population


Speaker:
Eric Wombwell, PharmD, BCIDP
Duration:
3 Hours 19 Minutes
Language:
Presented in EN, subtitles in EN, ES, DE, IT, and FR, handouts in EN, ES, DE, FR, and IT
Copyright:
18 Aug, 2022
Product Code:
POS078469
Media Type:
Digital Seminar


Description

It’s challenging to stay current on the evolving best treatments for c.difficile, community-acquired pneumonia and urinary tract infections. This session will also deliver an evidence-based assessment of penicillin allergies in the geriatric population. Eric Wombwell, PharmD, BCIDP, a board-certified infectious diseases pharmacist, will deliver the very latest updates so you can confidently choose the most effective medications for your older patients, while also considering the importance of minimizing adverse risks.

Credit


Self-Study Credit

This self-study program consists of 3.5 clock hours of continuing education instruction. Credit requirements and approvals vary by country and local regulatory bodies. Please save the course outline, the certificate of completion you receive from the activity and contact your local regulatory organization to determine specific eligibility and requirements. 



Handouts

Speaker

Eric Wombwell, PharmD, BCIDP's Profile

Eric Wombwell, PharmD, BCIDP Related seminars and products


Dr. Eric Wombwell is a board-certified infectious diseases pharmacist and clinical associate professor for the Department of Pharmacy Practice and Administration at the University of Missouri – Kansas City, School of Pharmacy. Eric completed his PharmD degree at the University of Missouri Kansas City, followed by an ASHP accredited pharmacy practice residency at the Kansas City VA Medical Center. Following residency, he accepted a full-time non-tenured clinical faculty position at the University of Missouri – Kansas City, School of Pharmacy. His teaching responsibilities include infectious diseases topics throughout the curriculum. Eric also has a clinical appointment at Centerpoint Medical Center rounding with the infectious diseases consult team and supporting antimicrobial stewardship efforts at the facility.

Eric is regularly published in pharmacy and infectious diseases research and is frequently invited to deliver continuing education presentations locally and nationally to various health-professional audiences. He is recognized for excellence in teaching through various awards, including the “Missouri Pharmacist Association – UMKC Faculty Member of the Year”, and the “University of Missouri – Kansas City Provost’s Award for Excellence in Teaching”.

 

Speaker Disclosures:
Financial: Eric Wombwell has an employment relationship with the University of Missouri. He receives a speaking honorarium, recording royalties, and a consulting fee from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Eric Wombwell is a member of the Society of Infectious Diseases Pharmacists, the Missouri Pharmacists Association, American Association of Colleges of Pharmacy, Infectious Diseases Society of America, and Centerpoint Medical Center.


Additional Info

Program Information

Access for Self-Study (Non-Interactive)

Access never expires for this product.


Objectives

  1. Evaluate beta-lactam reaction histories to make evidence-based decisions on the need to avoid beta-lactam therapies.
  2. Formulate effective care plans that limit risk for Clostridioides difficile infections.
  3. Select anti-infectives to treat Clostridioides difficile that reduce the risk for recurrent infections.
  4. Develop risk factor–based empiric antibiotic regimens for patients with suspected community-acquired pneumonia.
  5. Design safe and effective care plans for urinary tract infections.
  6. Choose effective antibiotic therapies that minimize risk for adverse effects in the geriatric population.

Outline

Penicillin Allergy
  • Side Effect vs. Allergy
  • Reassessing Allergy Statistics
  • Cephalosporin Cross-sensitivity
C. difficile Infections
  • Vancomycin vs. Fidaxomicin
  • Managing Recurrence
  • Probiotic Assessment
Community Acquired Pneumonia
  • Assess 2019 ATS/IDSA Guidelines
  • Streptococcus pneumonia Resistance
  • Evaluate and Contrast Oral Therapies for CAP
Urinary Tract Infections
  • E.coli Resistance
  • Efficacy and safety considerations antibiotics
  • Considerations for recurrent UTI

Target Audience

  • Nurses
  • Nurse Practitioners
  • Physician Assistants
  • Physicians
  • Physical Therapists
  • Occupational Therapists
  • Speech Language Pathologists
  • Nursing Home Administrators

Reviews

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to info@pesi.eu.

Please wait ...

Back to Top